Fundraising Fox
Zivo Bioscience
OTC: ZIVOKeego Harbor, US · Founded 2023 · Nevada corporation
Find your way into Zivo Bioscience
Sign up to see every warm intro you have to Zivo Bioscience
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Zivo Bioscience team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ZIVO Bioscience develops nutritional compounds and bioactive molecules from proprietary algal strains for applications in food, supplements, and other industries. The company licenses intellectual property in the form of proprietary algae cultures and derivatives.
Founders & leadership
AD
Andrew DahlExecutive
PR
PHILIP RICE IIExecutive
JG
John GormanExecutive
PR
Phillip RiceExecutive
JB
John B. PaynePresident and Chief Executive Officer; Chairman of the Board; Director
Board
RR
ROBERT RONDEAUBoard director
CM
CHRISTOPHE MAGGIOREBoard director
NM
NOLA MASTERSONBoard director
Reported raises · per SEC filings
Form D private placements$6.4M disclosed across 5 of 6 rounds · 2011–2023
▶$4MraisedJul 2023 · 1 investors · BiotechnologyRule 506(b)
▶$4MraisedJul 2023 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Allison A. CornellDirector
- Nola E. MastersonDirector
- Christopher D. MaggioreDirector
- John B. PayneExecutive Officer
- Keith R. MarchiandoExecutive Officer
- Offering amount
- $4M
- Amount sold
- $4M
- Sales commissions
- $280K
- Placement agents
- Maxim Group LLC
- First sale
- Jun 2023
- Incorporated
- Corporation, Nevada, 2023
- Federal exemptions
- 06b
▶$5MofferedMay 2018 · Other Health CareRule 506(b)
▶$5MofferedMay 2018 · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Philip Marshall Rice IIExecutive Officer, Director
- Andrew A DahlExecutive Officer
- Offering amount
- $5M
- Minimum investment
- $50K
- Sales commissions
- $350K
- Proceeds to insiders
- $250K
- Placement agents
- Cascade Partners BD, LLC
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$1.3MraisedOct 2016 · 6 investors · Other Health CareRule 506(b)
▶$1.3MraisedOct 2016 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- ANDREW DAHLExecutive Officer
- PHILIP RICE IIExecutive Officer, Director
- JOHN PAYNEDirector
- ROBERT RONDEAUDirector
- CHRISTOPHE MAGGIOREDirector
- NOLA MASTERSONDirector
- Offering amount
- $5M
- Amount sold
- $1.3M
- Minimum investment
- $50K
- Sales commissions
- $500K
- Proceeds to insiders
- $457K
- Placement agents
- Paulson Investment Company, LLC
- First sale
- Sep 2016
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$100KraisedMar 2014 · 1 investors · Other Health CareRule 506(b)
▶$100KraisedMar 2014 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- PHILIP RICEExecutive Officer, Director
- THOMAS COXDirector
- JOHN GORMANDirector
- ANDREW DAHLExecutive Officer
- JOHN PAYNEDirector
- CHRIS MAGGIOREDirector
- Offering amount
- $100K
- Amount sold
- $100K
- Minimum investment
- $100K
- Proceeds to insiders
- $25K
- First sale
- Mar 2014
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$700KraisedMar 2012 · 1 investors · Other Health CareRule 506(b)
▶$700KraisedMar 2012 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Phillip RiceExecutive Officer
- Andrew DahlExecutive Officer
- John GormanExecutive Officer, Director
- Howard BaerPromoter
- Offering amount
- $2M
- Amount sold
- $700K
- Minimum investment
- $600K
- Proceeds to insiders
- $160K
- First sale
- Dec 2011
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06
▶$332KraisedFeb 2012 · 1 investors · Other Health CareRule 506(b)
▶$332KraisedFeb 2012 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- John GormanExecutive Officer, Director
- Phillip RiceExecutive Officer, Director
- Howard BaerPromoter
- Andrew DahlExecutive Officer
- Offering amount
- $500K
- Amount sold
- $332K
- Minimum investment
- $332K
- Finders' fees
- $42.6K
- Proceeds to insiders
- $120K
- First sale
- Jan 2012
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Valuation · disclosed
Disclosed events$45.3Mvaluation at IPOJun 2021 · $5.00/share · 424B4
filing ↗Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Related companies · 6
Seeking AlphaSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
RobinhoodRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
StockTwitsStocktwits operates an online community platform where investors and traders share ideas, analysis, and trade discussions organized around stock tickers. The page presented is its community guidelines rather than a product description.
TradingViewTradingView is a charting platform and social network used by over 100 million traders and investors worldwide to analyze and trade across global financial markets. The platform provides tools for technical analysis, market data, and community collaboration for retail and institutional traders.
PublicPublic is a trading platform that allows users to buy and sell cryptocurrencies including Bitcoin, Ethereum, and memecoins through accounts managed by Zero Hash LLC, a New York State-licensed virtual currency business.
SoFiSoFi Technologies is a digital personal-finance company offering student and personal loans, mortgages, investing, banking and credit cards through one app; it went public on the Nasdaq in 2021 via SPAC.
Companies working in the same space as Zivo Bioscience.
In the news
Frequently asked questions
- What does Zivo Bioscience do?
- ZIVO Bioscience develops nutritional compounds and bioactive molecules from proprietary algal strains for applications in food, supplements, and other industries. The company licenses intellectual property in the form of proprietary algae cultures and derivatives.
- How much funding has Zivo Bioscience raised?
- Zivo Bioscience has disclosed $6.4M raised across 5 of its 6 known rounds.
- Where is Zivo Bioscience headquartered?
- Zivo Bioscience is headquartered in Keego Harbor, US.